GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » GE HealthCare Technologies Inc (NAS:GEHC) » Definitions » EPS (Diluted)

GE HealthCare Technologies (GE HealthCare Technologies) EPS (Diluted) : $3.42 (TTM As of Mar. 2024)


View and export this data going back to 2022. Start your Free Trial

What is GE HealthCare Technologies EPS (Diluted)?

GE HealthCare Technologies's Earnings per Share (Diluted) for the three months ended in Mar. 2024 was $0.81. Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was $3.42.

GE HealthCare Technologies's EPS (Basic) for the three months ended in Mar. 2024 was $0.82. Its EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2024 was $3.45.

GE HealthCare Technologies's EPS without NRI for the three months ended in Mar. 2024 was $0.81. Its EPS without NRI for the trailing twelve months (TTM) ended in Mar. 2024 was $3.44.

During the past 12 months, GE HealthCare Technologies's average EPS without NRIGrowth Rate was -7.80% per year. During the past 3 years, the average EPS without NRIGrowth Rate was -3.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 5 years, GE HealthCare Technologies's highest 3-Year average EPS without NRI Growth Rate was 8.40% per year. The lowest was -3.80% per year. And the median was 2.30% per year.


GE HealthCare Technologies EPS (Diluted) Historical Data

The historical data trend for GE HealthCare Technologies's EPS (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GE HealthCare Technologies EPS (Diluted) Chart

GE HealthCare Technologies Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
EPS (Diluted)
3.35 30.45 4.94 4.22 3.03

GE HealthCare Technologies Quarterly Data
Dec19 Dec20 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EPS (Diluted) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.41 0.91 0.82 0.88 0.81

Competitive Comparison of GE HealthCare Technologies's EPS (Diluted)

For the Health Information Services subindustry, GE HealthCare Technologies's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


GE HealthCare Technologies's PE Ratio Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, GE HealthCare Technologies's PE Ratio distribution charts can be found below:

* The bar in red indicates where GE HealthCare Technologies's PE Ratio falls into.



GE HealthCare Technologies EPS (Diluted) Calculation

EPS (Diluted) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Diluted EPS takes into account all of the outstanding dilutive securities that could potentially be exercised (such as stock options and convertible preferred stock) and shows how such an action would impact earnings per share.

GE HealthCare Technologies's Diluted EPS for the fiscal year that ended in Dec. 2023 is calculated as

Diluted EPS (A: Dec. 2023 ) = (Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(1568-183)/458.000
=3.02

GE HealthCare Technologies's Diluted EPS for the quarter that ended in Mar. 2024 is calculated as

Diluted EPS (Q: Mar. 2024 )=(Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(374-0)/459.000
=0.81

EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $3.42

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


GE HealthCare Technologies  (NAS:GEHC) EPS (Diluted) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


GE HealthCare Technologies EPS (Diluted) Related Terms

Thank you for viewing the detailed overview of GE HealthCare Technologies's EPS (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.


GE HealthCare Technologies (GE HealthCare Technologies) Business Description

Traded in Other Exchanges
Address
500 West Monroe Street, Chicago, IL, USA, 60661
GE HealthCare Technologies Inc is a globally medical technology, pharmaceutical diagnostics, and digital solutions innovator company. It has four operating segments; Imaging, Ultrasound, Patient Care Solutions (PCS), and Pharmaceutical Diagnostics (PDx). It earns a majority of its revenue from the Imaging segment.
Executives
Kevin Michael O'neill officer: CEO, PDx 500 W. MONROE STREET, CHICAGO IL 60661
Roland Rott officer: CEO, Ultrasound 500 W. MONROE STREET, CHICAGO IL 60661
James Saccaro officer: Chief Financial Officer ONE BAXTER PARKWAY, DEERFIELD IL 60015
Jan Makela officer: CEO, Imaging 500 W. MONROE STREET, CHICAGO IL 60661
Taha Kass-hout officer: Chief Technology Officer 500 W. MONROE STREET, CHICAGO IL 60661
Kenneth R. Stacherski officer: Ch. Supply Chain & Serv. Ofc. 500 W MONROE, CHICAGO IL 60661
Culp H Lawrence Jr director GENERAL ELECTRIC COMPANY, ONE FINANCIAL CENTER, SUITE 3700, BOSTON MA 02111
William J Stromberg director 100 E. PRATT STREET, BALTIMORE MD 21202
Thomas J. Westrick officer: CEO, Patient Care Solutions 500 W. MONROE STREET, CHICAGO IL 60661
Yang Watkin Phoebe L. director C/O DOXIMITY, INC., 500 THIRD STREET, SAN FRANCISCO CA 94107
Rodney F Hochman director 21919 30TH DR SE, BOTHELL WA 98021
Tomislav Mihaljevic director ONE FINANCIAL CENTER, SUITE 3700, BOSTON MA 02111
Lloyd Jr Howell director 8283 GREENSBORO DRIVE, MCLEAN VA 22102
Anne T Madden director C/O HONEYWELL 300 S. TRYON STREET, CHARLOTTE NC 28202
Frank R Jimenez officer: GC & Corporate Secretary GE HEALTHCARE TECHNOLOGIES INC., 500 W. MONROE ST., CHICAGO IL 606061